Search

Search Results

• 

  Comparing the effect of cardiac biomarkers on the outcome of normotensive patients with acute pulmonary embolism

  Yaser Jenab, Marzieh Pourjafari, Maryam Sotoudeh, Masoumeh Lotfi-tokaldany, Nasrin Etesamifard, Shapour Shirani, Arash Jalali, Younes Nozari, Hamid-reza Poorhosseini

  2017-05-18

  Published: May 18, 2017

  1288

  PDF: 755
• 

  The impairment of the Growth Hormone/Insulin-like growth factor 1 (IGF-1) axis in heart failure: A possible target for future therapy

  Lucrezia Piccioli, Michele Arcopinto, Andrea Salzano, Roberta D'Assante, Alessandra Schiavo, Francesca M. Stagnaro, Anna Lombardi, Veronica Panicara, Pietro Valente, Giuseppe Vitale, Filippo M. Sarullo, Francesco Giallauria, Alberto M. Marra

  2018-09-05

  Published: September 5, 2018

  1448

  PDF: 996
• 

  Can serum progranulin level be used as a prognostic biomarker in non-small cell lung cancer?

  Nevin Taci Hoca, Ebru Ünsal, Koza Murat, Arzu Ertürk, Nermin Çapan

  2022-11-14

  Published: November 14, 2022

  864

  PDF: 187
• 

  Anabolic hormones and heart failure with preserved ejection fraction: looking for Ariadne’s thread

  Mariarosaria De Luca, Giulia Crisci, Federica Giardino, Valeria Valente, Ilaria Amaranto, Olimpia Iacono, Roberta D'Assante, Francesco Giallauria, Alberto M. Marra

  2021-08-03

  Published: August 3, 2021

  1820

  PDF: 724

• Utility of systemic immune-inflammation index as a serum biomarker to differentiate between complicated and simple para-pneumonic effusion

  Nikhil Rajvanshi, Prawin Kumar, Jagdish Prasad Goyal

  2023-09-07

  Published: September 7, 2023

  619

  PDF: 11

• An in-depth investigation of serum Krebs von den Lungen-6 and other biomarkers in COVID-19 severity and mortality

  Andro Pramana Witarto, Alfian Nur Rosyid, Bendix Samarta Witarto, Shidi Laras Pramudito, Achmad Januar Er Putra

  2024-07-26

  Published: July 26, 2024

  330

  PDF_EARLY VIEW: 108

  SUPPLEMENTARY MATERIAL: 19

• Monocyte related haematological indices in acute exacerbations of COPD – a new biomarker?

  Višnja Dukić, Davorka Muršić, Sanja Popović Grle, Marko Jakopović, Alen Ružić, Andrea Vukić Dugac

  2023-09-25

  Published: September 25, 2023

  695

  PDF_early view: 322
• 

  Suppression of tumorigenicity 2 after exercise: a systematic review

  Ana Martins da Costa, Rafael Teixeira, Eduardo M. Vilela, Ana Tavares, Susana Torres, Francisco Sampaio, Madalena Teixeira, Ricardo Fontes-Carvalho, José Pedro Nunes

  2021-08-10

  Published: August 10, 2021

  1387

  PDF: 541

• Active versus latent pulmonary tuberculosis: which one is the appropriate distinguishing biomarker?

  Rizk Sayad R. Sarhan, Omnia Y. Habashy, Raafat R. Mohammed, Yasmin M. Marei

  2024-07-25

  Published: July 25, 2024

  227

  PDF_EARLY VIEW: 95

  SUPPLEMENTARY MATERIAL: 10

• Point-of-care test for tuberculosis: a boon in diagnosis

  Devika Tayal, Prabhpreet Sethi, Prerna Jain

  2023-04-28

  Published: April 28, 2023

  1620

  PDF: 631
• 

  Factors predicting mortality among patients with COVID-19 associated hospital acquired pneumonia: insights from a tertiary care center

  Nabila Kanwal, Humza Thobani, Ainan Arshad, Priya Ashok Kumar, Fatima Amjad, Safia Awan, Muhammad Irfan

  2022-12-14

  Published: December 14, 2022

  2267

  PDF: 284
• 

  Association between neutrophil to lymphocyte ratio and mortality among community acquired pneumonia patients: a meta-analysis

  Osama Alzoubi, Asim Khanfar

  2021-12-13

  Published: December 13, 2021

  2567

  PDF: 1130

  Supplementary 1: 113

  Supplementary 2: 93

  Data Analysis: 163